🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Markets Up on Sunny Holiday Outlook

Published 11/23/2020, 05:40 AM
Updated 07/09/2023, 06:31 AM
US2000
-
AAPL
-
HAL
-
PFE
-
NFLX
-
AZN
-
AAL
-
MRNA
-
BNTX
-

Market indexes happily churned along Monday with a favorable outlook on the latest positive test results from AstraZeneca (NASDAQ:AZN) AZN and Oxford University, pointing to a post-pandemic world somewhat in sight next year. It follows the positive Pfizer PFE-BioNTech BNTX Covid vaccine results two Mondays ago and Moderna’s MRNA positive results last week. One dosage regimen for the AstraZeneca drug also reported 90% efficacy, roughly in-line with the early reports from the other pharma companies.

Yet AstraZeneca stock took a 3.8% hit on the day, perhaps in that headline efficacy numbers averaged 70% — still an encouraging level based on historical vaccine trials — instead of the 90%+ levels of the competitors’ candidates. However, normal refrigeration capacity would be all that is needed for the AstraZeneca vaccine; unlike the others, it is not an mRNA treatment. It does not need to be subjected to the severely cold temperatures to keep the other vaccines intact.

So the market found favor in oilfield services giant Halliburton HAL, up 9%, and American Airlines (NASDAQ:AAL) AAL, also up 9%, on expected pent-up demand in fuel and travel to accelerate in 2021. Meanwhile, Apple AAPL and Netflix (NASDAQ:NFLX) NFLX dropped 3% and 2.4%, respectively, on expectations that the “stay at home” model may perhaps be a tad overbought at this stage. The small-cap Russell 2000 led the way yet again, following three straight up weeks, +1.85% on the day. The Dow rose 1.12%, followed by the S&P 500 at +0.57%, with the tech-heavy Nasdaq +0.22% this Monday.

Also, President-elect Joe Biden announced he intends to nominate former Fed Chair Janet Yellen as his administration’s Treasury Secretary, satisfying Wall Streeters who may have feared Biden may have chosen a more anti-Wall Street economist like Senator Elizabeth Warren. By most accounts, Yellen’s tenure as the first-ever Fed Chair was a solid and transparent one. This news likely only helped push positive sentiment a tad further.

Finally, the National Retail Federation (NRF) announced it expects U.S. holiday shopping season to grow 5.2% year over year, based on some of the pent-up demand mentioned earlier. In addition, the pandemic period has turned American consumers into American savers; though they may not be able to see their loved ones over the holidays, spending on gifts looks to come in higher for the year.

Questions or comments about this article and/or its author? Click here>>

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AstraZeneca PLC (AZN): Free Stock Analysis Report

Apple Inc. (NASDAQ:AAPL): Free Stock Analysis Report

Halliburton Company (NYSE:HAL): Free Stock Analysis Report

Pfizer Inc. (NYSE:PFE): Free Stock Analysis Report

Moderna, Inc. (NASDAQ:MRNA): Free Stock Analysis Report

Netflix, Inc. (NFLX): Free Stock Analysis Report

American Airlines Group Inc. (AAL): Free Stock Analysis Report

BioNTech SE Sponsored ADR (NASDAQ:BNTX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.